Myriad Genetics
MYGN
#6699
Rank
$0.66 B
Marketcap
$7.09
Share price
-3.27%
Change (1 day)
-56.66%
Change (1 year)

Myriad Genetics (MYGN) - Cash on Hand

Cash on Hand as of September 2025 : $0.14 Billion USD

According to Myriad Genetics's latest financial reports the company has $0.14 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Myriad Genetics - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$0.10 B-27.32%
2023-12-31$0.14 B22.63%
2022-12-31$0.11 B-66.09%
2021-12-31$0.33 B
2020-06-30$0.21 B59.09%
2019-06-30$0.13 B-24.2%
2018-06-30$0.18 B19.84%
2017-06-30$0.15 B-5.22%
2016-06-30$0.15 B9.81%
2015-06-30$0.14 B-22.32%
2014-06-30$0.18 B-49.94%
2013-06-30$0.37 B9.33%
2012-06-30$0.34 B-1.71%
2011-06-30$0.34 B-14.08%
2010-06-30$0.40 B27.26%
2009-06-30$0.31 B-3.61%
2008-06-30$0.32 B53.53%
2007-06-30$0.21 B-5.99%
2006-06-30$0.22 B100.05%
2005-06-30$0.11 B-1.32%
2004-06-30$0.11 B58.52%
2003-06-30$72.77 M-0.41%
2002-06-30$73.07 M-42.56%
2001-06-30$0.12 B58.03%
2000-06-30$80.5 M713.15%
1999-06-30$9.9 M-32.19%
1998-06-30$14.6 M-7.01%
1997-06-30$15.7 M18.94%
1996-06-30$13.2 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Bio-Rad Laboratories
BIO
$1.41 B 875.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
$1.00 B 589.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
$6.63 M-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$1.47 B 916.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$7.73 B 5,218.43%๐Ÿ‡บ๐Ÿ‡ธ USA